XCT Insights
Stay Updated
Fullerene research, applications and company updates, delivered occasionally.
Latest from XCT
View all
A fullerene distributor does more than transfer C60 or C70 from one container to another. The distributor becomes part of the material’s identity, documentation and traceability chain. When a laboratory orders a repeat batch, a formulation team asks whether two lots are comparable, or a customs broker needs product information, the quality of the answer depends on records maintained between the original supplier and the final customer.
This makes fullerene distribution a technical operation rather than a conventional commodity-wholesale model. A distributor must decide which materials to stock, how to preserve their documented identity, which analytical files to pass downstream and how to distinguish a qualified research or industrial inquiry from an unsupported consumer or medical request.
This guide explains the practical framework for distributing pristine Fullerene C60 and C70. It focuses on product scope, supplier qualification, batch control, storage, customer communication and international delivery—not on speculative market-size or profit claims.
The first decision is not how much fullerene to purchase. It is which chemical identities and grades the target market actually requires.
Pristine C60 and C70 are distinct molecular materials. C60 contains sixty carbon atoms in a highly symmetrical cage, while C70 contains seventy carbon atoms in a more elongated cage. Their different molecular masses, symmetries and optical behavior mean they cannot be treated as interchangeable grades of a generic “fullerene powder.” The accepted nomenclature for these cages is described by IUPAC.1
A distributor’s product master should identify at least:
| Field | Why it matters |
|---|---|
| Product identity | Distinguishes pristine C60, pristine C70, mixtures and functionalized derivatives. |
| CAS number and formula | Connects the quotation, label, SDS, COA and customer order to the same material. |
| Purity statement | Should identify the method or calculation basis instead of presenting an isolated percentage. |
| Physical form | Affects sampling, weighing, storage and customer handling. |
| Batch or lot number | Links the supplied container to batch-specific records. |
| Intended-use boundary | Prevents research materials from being promoted as approved consumer or medical products. |
Product descriptions should use the identity actually documented by the supplier. A water-dispersible formulation, fullerol, functionalized derivative or fullerene-containing oil is not pristine C60 simply because C60 was used as a starting material.
Distributor inventory should reflect identifiable regional demand rather than a broad list of possible fullerene applications. The most useful evidence comes from existing customer inquiries, sample requests, university and industrial research activity, and the analytical requirements attached to those requests.
Academic and institutional laboratories may need small quantities, a clearly identified batch, an SDS and analytical information appropriate to a synthesis or characterization project. A laboratory developing C60 derivatives may focus on soluble fullerene composition because related fullerene species can create additional products during functionalization. A spectroscopy group may prioritize identity and preparation conditions.
For thin films, organic electronics and photovoltaic research, customers may ask about fullerene composition, residual processing materials, batch comparability and solution-processing behavior. C60 or C70 selection should follow the device architecture and processing method rather than a universal claim that one cage provides better performance.
The newly published perovskite commercialization guide explains why scale-up decisions require material consistency and reliability evidence beyond an isolated laboratory efficiency result.
Formulators need to evaluate whether a selected fullerene can be dispersed in the actual base material and whether the sample remains stable under the formulation process. Published tribology research can establish a reason to test C60, but it does not define a universal concentration or guarantee wear reduction in every oil or contact system.
Fullerenes have been studied in biomedical, photodynamic and antioxidant-related research. Distribution into these sectors requires particularly clear intended-use language. Research findings must not be converted into claims that pristine C60 or C70 is approved for treatment, ingestion, injection or consumer use.
A distributor should record the customer’s material request and research context without presenting itself as a medical-product regulator or making a therapeutic recommendation.
A distributor needs evidence that the upstream supplier can identify the product, connect it to a batch and communicate changes. Promotional descriptions of manufacturing technology are not a substitute for these operational capabilities.

Initial supplier qualification should establish:
A supplier’s claim that a process does not intentionally use a particular metallic catalyst is not equivalent to a measured “zero-metal” result. When specified elements matter to the customer’s process, the parties should agree on the elements, method, reporting basis and applicable batch result.

Likewise, an HPLC percentage should state what was measured. HPLC commonly addresses the relative composition of soluble fullerene species under a defined method. Residual solvents, selected elements, water or insoluble material may require different measurements. XCT’s C60 characterization guide and C70 characterization guide explain these evidence boundaries.
Traceability is lost when a distributor can identify the supplier but cannot connect a customer shipment to the original batch. The distributor’s receiving, inventory and order records should preserve that connection.
At receipt, compare the purchase order, packing list, container identity, quantity, batch number and supplied documents. Record any visible container damage, seal discrepancy or mismatch before the material enters saleable inventory. If a sample is retained, its container should preserve the same batch identity and storage history.
When one supplier batch is divided across several customer orders, each customer record should still point back to that batch. If material is repacked, the distributor must also record the repacking date, new container identity, quantity transferred and personnel or procedure responsible for the operation.

Repacking introduces contamination, labeling and exposure risks. It should not be treated as a simple warehouse task. If the distributor lacks an appropriate controlled process, retaining the original sealed supplier packaging may be the safer operating model.
A Certificate of Analysis, product specification and Safety Data Sheet answer different questions.
The COA records results associated with a particular batch or lot. It should allow the distributor and customer to identify the tested material, test items, results and approving source. An example COA can help during preliminary review, but it should not be represented as the result for a different shipped batch.
The product specification defines agreed attributes and acceptance limits. It may remain applicable across multiple batches, subject to revision control.
The SDS communicates hazard, handling, storage and emergency information. Under the United States Hazard Communication framework, labels and SDSs form part of a standardized system for communicating chemical hazards.2 OSHA also describes distributor responsibilities for passing applicable SDS information to downstream commercial customers.3
A distributor should maintain the document version and revision date supplied with each product. When an SDS or specification changes, the updated file should not silently replace the historical record connected to an earlier shipment.
Storage requirements should follow the current supplier documentation for the actual product. In general, fullerene powders should be kept in sealed containers and protected from contamination and unnecessary exposure to light or moisture. The distributor should confirm temperature, container and segregation requirements rather than inventing a universal storage condition.
Handling dry nanoscale or fine powders also requires an exposure-control approach. NIOSH guidance for engineered nanomaterials emphasizes controlling worker exposure during handling and downstream processing.4 The appropriate controls depend on the operation, powder form, quantity and available exposure information.

Warehouse and laboratory procedures should address:
A distributor should not promise that packaging eliminates degradation or aggregation. Packaging controls exposure conditions; batch integrity still depends on the container, storage history, material properties and handling after delivery.
Many failed quotations begin with an incomplete request such as “C60 price” or “bulk fullerene.” Before sending the inquiry upstream, the distributor should determine what the customer is actually qualifying.
A useful technical RFQ identifies the product, target purity and purity method, quantity, application, destination, packaging preference and required records. If the customer has a critical impurity concern, it should be expressed as a defined analytical requirement rather than a general request for “the highest quality.”
Price comparisons should use equivalent commercial scope. Two quotations are not directly comparable if one includes additional testing, different packaging, different delivery terms or a different purity basis.
Sample evaluation should also have a defined purpose. The customer might use the sample to verify solution preparation, chromatographic composition, reaction behavior, coating uniformity or another project-specific variable. Passing one sample test does not establish that every future batch is identical; it helps define the acceptance criteria for subsequent supply.
A specialist distributor adds value by asking the right questions and preserving reliable information. It should not promise a device efficiency, lubricant performance, biological response or regulatory outcome.
When a customer asks whether C60 or C70 is suitable, the distributor can clarify the intended experiment, provide the relevant specification and analytical records, and direct the customer to appropriate technical literature. The customer’s research or manufacturing team remains responsible for selecting the test conditions and deciding whether the material meets the project requirement.
This distinction is commercially useful. It produces better inquiries, reduces unnecessary sampling and prevents a general marketing claim from becoming an unintended technical guarantee.
International distribution requires a clear agreement on the tasks, costs and risk associated with delivery. ICC’s Incoterms rules are designed to clarify these responsibilities in sales contracts.5 The selected term should identify a named place precisely; a freight-paid destination does not always mean that risk transfers at arrival.
The distributor and supplier should confirm the commercial invoice, packing list, product identity, quantity, SDS, COA and other records required for the actual destination. Customs classification and import requirements should be checked for the product form and jurisdiction rather than copied from an unrelated shipment.
Local inventory can reduce repeated international shipments, but only when regional demand justifies the stock and the distributor can maintain suitable storage and traceability. A distributor should begin with a product and quantity range supported by identifiable customer programs, then expand after repeat demand is demonstrated.
A useful proposal to XCT should describe the distributor’s operating capability rather than making a broad request for exclusivity.
Include the intended territory, existing customer sectors, target C60 or C70 products, expected initial quantities, storage facilities, technical-sales capability, quality-document workflow, import experience and the type of supplier support required. If local repacking is planned, describe the relevant facilities and traceability process.
XCT can then review whether the proposed market, product range and operating model are compatible with the available supply and documentation. Product availability, territory, pricing, packaging, lead time and any channel arrangement should be confirmed in the resulting commercial agreement; they should not be assumed from general website content.
A fullerene distributor purchases material for resale and must preserve product identity, batch traceability, document versions, storage conditions and downstream customer records. An end buyer normally qualifies the material for its own research or manufacturing process.
Only when identifiable customer demand supports both products. C60 and C70 have different molecular identities, analytical fingerprints and application roles, so one should not be stocked as an automatic substitute for the other.
An example COA may be used for preliminary format review, but it should not be represented as the result for another batch. The shipped material should be connected to its applicable batch-specific documentation.
The distributor should provide its intended territory, customer sectors, target products, expected quantities, storage and quality capabilities, import experience and required commercial or technical support.
No. Territory, exclusivity, pricing, availability, lead time, documentation and purchase commitments must be defined in the actual commercial agreement and confirmed for relevant orders.
Submit your product, purity, quantity, application, destination country, and documentation requirements. Our team will help confirm availability, COA, MSDS/SDS, packaging, and quotation details.